Insider trades
Konstantinos Xynos, Chief Officer of Replimune Group REPL, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $137.2K. The latest trade was on 05/18.
Konstantinos Xynos
Chief Medical Officer
- Company
- Replimune Group REPL
- First filing
- 23/04/04
- Trades
- 17 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$137.2K
- Last trade
- 05/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Replimune GroupREPL | Open-market sale | 05/18 | 05/20 | 14,023 sh | $5.08 | $71,236.84 | −5.6% |
Replimune GroupREPL | Open-market sale | 25/11/17 | 25/11/19 | 7,248 sh | $9.10 | $65,956.8 | −4.9% |
Replimune GroupREPL | Open-market sale | 25/05/20 | 25/05/22 | 7,952 sh | $8.06 | $64,093.12 | −5.1% |
Replimune GroupREPL | Open-market sale | 24/11/18 | 24/11/20 | 7,246 sh | $10.78 | $78,111.88 | −6.2% |
Replimune GroupREPL | Open-market sale10b5-1 plan | 24/06/07 | 24/06/10 | 15,881 sh | $7.50 | $119,107.5 | −11.9% |
Replimune GroupREPL | Open-market sale | 24/05/16 | 24/05/20 | 6,367 sh | $6.47 | $41,194.49 | −4.6% |
Replimune GroupREPL | Open-market sale | 23/11/16 | 23/11/17 | 7,313 sh | $10.92 | $79,857.96 | −6.1% |
Replimune GroupREPL | Open-market sale | 23/05/16 | 23/05/18 | 771 sh | $18.05 | $13,916.55 | −0.6% |